MORGAN STANLEY - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 221 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q2 2022. The put-call ratio across all filers is 12.07 and the average weighting 0.1%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$25,672,032
-21.2%
558,209
-1.5%
0.00%0.0%
Q2 2023$32,574,858
+67.0%
566,815
+9.0%
0.00%
+50.0%
Q1 2023$19,501,615
+15.4%
520,043
-13.8%
0.00%0.0%
Q4 2022$16,897,406
-15.4%
603,048
-15.1%
0.00%
-33.3%
Q3 2022$19,962,000
-30.6%
710,384
-14.1%
0.00%
-25.0%
Q2 2022$28,763,000
+42.5%
826,791
+47.0%
0.00%
+33.3%
Q1 2022$20,188,000
+40.1%
562,395
-9.1%
0.00%
+50.0%
Q4 2021$14,411,000
+46.5%
618,742
+19.6%
0.00%
+100.0%
Q3 2021$9,837,000
+17.8%
517,435
+24.9%
0.00%0.0%
Q2 2021$8,350,000
+33.4%
414,225
+21.3%
0.00%0.0%
Q1 2021$6,258,000
-6.3%
341,600
+2.9%
0.00%0.0%
Q4 2020$6,676,000
+267.6%
331,908
+242.7%
0.00%
Q3 2020$1,816,000
-33.9%
96,838
-20.8%
0.00%
-100.0%
Q2 2020$2,746,000
-21.1%
122,281
-47.9%
0.00%0.0%
Q1 2020$3,482,000
+6.1%
234,619
+38.0%
0.00%0.0%
Q4 2019$3,281,000
+38.6%
170,068
+42.4%
0.00%0.0%
Q3 2019$2,367,000
-28.9%
119,407
-24.3%
0.00%0.0%
Q2 2019$3,328,000
-56.7%
157,644
-58.1%
0.00%
-50.0%
Q1 2019$7,684,000
+87.4%
376,127
+82.6%
0.00%
+100.0%
Q4 2018$4,100,000
-8.9%
206,015
-11.9%
0.00%0.0%
Q3 2018$4,499,000
+60.4%
233,864
+27.3%
0.00%0.0%
Q2 2018$2,804,000
-22.5%
183,720
-4.8%
0.00%0.0%
Q1 2018$3,619,000
+46.8%
193,011
+50.6%
0.00%0.0%
Q4 2017$2,466,000
+157.7%
128,203
+139.3%
0.00%
Q3 2017$957,000
-55.1%
53,578
-55.2%
0.00%
-100.0%
Q2 2017$2,133,000
-23.9%
119,464
-38.3%
0.00%
Q1 2017$2,804,000
-48.2%
193,552
-34.1%
0.00%
-100.0%
Q4 2016$5,408,000
+66.0%
293,750
+71.1%
0.00%0.0%
Q3 2016$3,257,000
+323.0%
171,710
+259.3%
0.00%
Q2 2016$770,000
+64.2%
47,794
+22.3%
0.00%
Q1 2016$469,000
-22.1%
39,078
-7.7%
0.00%
Q4 2015$602,000
+1670.6%
42,349
+1396.4%
0.00%
Q3 2015$34,000
-83.1%
2,830
-75.2%
0.00%
Q2 2015$201,000
-83.6%
11,423
-86.0%
0.00%
Q1 2015$1,224,000
+302.6%
81,815
+212.7%
0.00%
Q4 2014$304,000
-62.3%
26,160
-62.2%
0.00%
Q3 2014$806,00069,1600.00%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q2 2022
NameSharesValueWeighting ↓
LAM GROUP, INC. 130,250$3,649,6053.75%
SHAKER INVESTMENTS LLC/OH 81,287$2,277,6621.41%
Mesirow Institutional Investment Management, Inc. 374,414$10,491,0801.38%
OBERWEIS ASSET MANAGEMENT INC/ 134,000$3,754,6800.80%
Portolan Capital Management 270,791$7,587,5640.75%
Hillsdale Investment Management Inc. 172,238$4,826,1090.41%
Capital Impact Advisors, LLC 14,669$411,0250.40%
Watershed Asset Management, L.L.C. 9,555$267,7310.34%
Quantedge Capital Pte Ltd 35,153$984,9870.33%
FEDERATED HERMES, INC. 3,284,217$92,023,7600.25%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders